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AbstrAct:
The p53 tumor suppressor induces apoptosis in response to genotoxic and environmental 
stresses. Separately from its functions as a transcription factor, it is also capable to be 
translocated to the mitochondria and plays a critical role in transcription-independent 
mitochondrial apoptosis. We previously demonstrated that Tid1 interacts with p53, 
resulting in mitochondrial translocation of the complex and induction of intrinsic 
apoptosis [1]; however, the mechanism how they interact has been unknown. In 
this study, far western analyses demonstrated that Tid1 directly interacted with p53. 
Using domain deletion mutant constructs, we determined that DnaJ domain of Tid1 
was necessary for the interaction, while either N- or C-terminal domains of p53 were 
sufficient for the interaction. In breast cancer cells, depletion of Tid1 by short hairpin 
RNA (shRNA) led to absence of p53 accumulation at mitochondria and resistance to 
apoptosis under hypoxic or genotoxic stresses. Our studies imply that Tid1 could 
be important in the potential combination chemotherapies of p53-related cancers.
IntroductIon 
p53 has been known for many years to play a large 
role as a transcription factor in the nucleus of cells in 
regulation of the transcription of over 150 target genes 
involved in growth, proliferation, senescence, apoptosis, 
and invasion [2,3,4,5,6]. The use of a temperature sensitive 
p53Val135 mutant in combination with inhibitors of 
transcription and translation established that p53 also 
has a transcription-independent function in apoptosis 
[7,8]. In 2000, it was reported that a small fraction of p53 
induced by cellular stress would quickly translocate to the 
mitochondria as a first wave rapid response only during 
a p53-dependent apoptotic program [2,7,9,10,11]. This 
translocation was a general phenomenon to wildtype p53 
harboring malignant and non-malignant cells and occurred 
prior to mitochondrial membrane potential changes, the 
apoptotic release of cytochrome c, and activation of the 
caspase cascade [9,10]. The direct targeting of p53 to the 
mitochondria by fusion of the mitochondrial import leader 
peptide of human ornithine transcarbamylase, or the 
transmembrane domains of anti-apoptotic proteins Bcl-
xL or Bcl2 to p53 was sufficient to launch an apoptotic 
program [7,9,12]. 
Tid1 is a type I member of the DnaJ family of 
molecular chaperones as it possesses not only the 
DnaJ domain, but also Cys-rich and G/F rich domains 
[13,14,15,16,17]. This DnaJ domain, in particular the HPD 
motif, has been shown to be important for the interaction 
with the heat shock 70 [Hsp70] family of proteins to 
allocate for substrate specificity as well as ATPase activity 
[15,17,18,19]. The interaction between Tid1 and Hsp70 has 
been demonstrated in a number of studies, and also shown 
to be significant for the interaction with other proteins 
such as the viral Tax protein and the ErbB-2 receptor 
tyrosine kinase [20,21]. Mutations in the DnaJ domain 
affected the ErbB-2 interaction that lead to reductions in 
Tid1-mediated apoptosis [21]. The N-terminal domain 
of Tid1 has also been relatively well characterized on 
the basis of the presence of consensus sequences and 
by mutational studies. The consensus mitochondrial 
targeting (MAARCS) and cleavage sequences (LRPGV) 
allow for the translocation of Tid1 to the mitochondria 
where metalloproteases cleave the precursor to form the Oncotarget 2010; 1:  396 - 404 397 www.impactjournals.com/oncotarget
mature protein [22,23,24]. Tid1 mutants of either isoform, 
which lack the N-terminal targeting sequence, did not co-
localize with the mitochondria, but rather were dispersed 
throughout the cytosol [22]. Tid1 was previously shown to 
interact with p53 in vivo, particularly in the mitochondrial 
fractions, leading to apoptosis [1]; however, little is known 
of the nature and significance that protein domains of Tid1 
and p53 play in their interaction. Here we show that Tid1 
directly interacts with p53 mostly likely through its DnaJ 
domain and its depletion induces resistance to stresses by 
inhibiting the p53 localization to the mitochondria.
results
cellular localization of tid1 full length and its 
deletion mutants.
We first tested whether the loss of certain domains 
of Tid1 had any effect on the mitochondrial localization. 
The pEGFP-Tid1 wildtype and mutants constructs (Fig. 
1A) were transfected into the human breast cancer MCF-7 
cell line and immunoblotting was performed using anti-
A
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Figure 1: cellular localization of tid1 full length and its deletion mutants. MCF-7 cells were transfected with Tid1 constructs 
to overexpress Tid1 full length or its domain deletion mutants (A) Schematic diagram of Tid1-EGFP full length or the domain deletion 
mutants (B) Immunoblotting analysis for Tid1 and its mutants. (C) Tid1-EGFP transfected cells labeled with anti-mtHsp70 were visualized 
by confocal microscope. (D) Mander’s Overlap Co-efficient between the various Tid1 constructs and mtHsp70 as determined by Image J 
Intensity Correlation Analysis Software, with 1 being a high colocalization and 0 being low (n=4). Results are representative of a minimum 
of two independent experiments. (E) Cells were subjected to biochemical fractionation (W = whole cell extracts; C = cytosolic fraction; and 
M = mitochondrial fraction) followed by immunoblotting. Purity of the fractions was determined by immunoblotting with anti-mtHsp70 
(mitochondrial) and anti-β-tubulin (cytosolic) antibodies.Oncotarget 2010; 1:  396 - 404 398 www.impactjournals.com/oncotarget
GFP antibody to checked the molecular weight of the 
generated fusion proteins and their proper processing (Fig. 
1B). For detection of the mitochondria, immunostaining 
and confocal microscopy were performed with the anti-
mtHsp70 antibodies. Similar to endogenous Tid1, the full 
length form of Tid1-GFP was found to mainly co-localize 
with the mtHsp70 staining, indicating that this fusion 
protein also translocated to the mitochondria (Fig. 1C). 
Consecutive truncations of the C-terminal end of Tid1 
did not appear to affect the mitochondrial localization of 
the Tid1 mutants (Fig. 1C). As expected, the loss of the 
N-terminal domain (amino acid residues 1-88) resulted in 
a dramatic reduction of co-localization of the Tid1 mutants 
with mtHsp70 (Fig. 1C). We quantified the degree of co-
localization of our exogenous Tid1 and mtHsp70 (Fig. 
1D) and found that Tid1-FL and the N-terminal containing 
mutants all had greater than 0.70 correlation coefficients 
indicating relatively high co-localization with mtHsp70, 
whereas the N-terminal deletion constructs had lower co-
localization correlation coefficients (approximately 0.50). 
Biochemical fractionations using a cell compartment 
fractionation  kit,  confirmed  our  immunofluorescent 
findings that full length Tid1 and the mutants possessing 
the N-terminal domain, were found primarily in the 
mitochondrial fraction of the cell (Fig. 1E). Note that there 
are two bands present in the whole cell extracts of the 
Tid11-168, Tid11-235, and Tid11-292 mutants as these mutants 
are processed in the mitochondria in the same manner as 
endogenous full length Tid1. Hence, our biochemical and 
immunofluorescent data confirm previous notions of the 
importance of the N-terminal domain in the mitochondrial 
localization of Tid1.
cellular localization of p53 full length and its 
deletion mutants
Parallel immunofluorescent experiments to the Tid1 
mutants were performed with the pDsRed2-p53 wildtype 
and mutants (Fig. 2A). We transfected these constructs 
into MCF-7 cells, and through immunoblotting with 
anti-DsRed2  antibody,  checked  the  molecular  weight 
of  the  generated  fusion  proteins  (Fig.  2B). A  majority 
of exogenous full length p53 and p531-363 was largely 
found in the nucleus of cells although some staining in 
the cytoplasmic portions of the cells was detected (Fig. 
2C).  An  average  co-localization  correlation  coefficient 
of 0.70 was quantitated for full length p53 and mtHsp70 
(Fig.  2D),  indicating  some  colocalization.  Loss  of  the 
C-terminal region of p53 as with p531-98, resulted in the 
nuclear exclusion of p53, due to the absence of the nuclear 
localization sequence (NLS), and relatively high mtHsp70 
colocalization with a correlation coefficient of 0.90. p531-
363 was primarily nuclear with a correlation coefficient 
of  0.60  (Fig.  2D).  The  C-terminal  domain  mutant, 
p53293-393 has a large proportion found in the insoluble 
cytoskeletal  fraction  (data  not  shown).  These  findings 
agree with those from Wadhwa et al. [25], that the NLS 
is required for the nuclear translocation of p53; however, 
the existence of a cytoplasmic sequestration domain in the 
C-terminal region of p53 can lend to nuclear exclusion.
the dnaJ domain of tid1 is required for the 
interaction to both the n- and c-terminal domains 
of p53.
Next, we determined which domains of both Tid1 
and p53 were required for their interaction. The various 
pEGFP-Tid1 constructs were transfected into MCF-7 
cells to exogenously produce these Tid1 mutant proteins. 
Protein lysates were then utilized for immunoprecipitation 
with a rabbit polyclonal anti-GFP antibody, polyclonal 
anti-p53 antibody, or normal rabbit IgG and Protein A/G 
agarose beads. These samples were then immunoblotted 
with a monoclonal anti-GFP antibody. A consecutive loss 
of the non-homologous C-terminal, Cys-rich, and G/F-
rich domains starting from the C-terminal end of Tid1 
did not appear to interfere with the interaction between 
Tid1 and endogenous p53. Although the Tid189-447 mutant 
mislocalized  in  the  cell  (Fig.  1C),  we  still  detected  a 
relatively strong interaction between this mutant and p53 
(Fig. 3A). The additional loss of the DnaJ domain from 
the N-terminal end of Tid1 resulted in the abrogation of 
the  Tid1/p53  interaction  (Fig.  3A).  Thus,  consecutive 
domain deletions from either end of the Tid1 protein have 
exemplified the importance of the DnaJ domain for the 
formation of this protein complex. 
To determine the region of interaction on p53, 
pDsRed2-p53 constructs were transfected in MCF-7 cells 
and the protein lysates were used for immunoprecipitation 
with the monoclonal DsRed2 antibody, monoclonal anti-
Tid1 antibody, or normal mouse IgG and Protein A/G-
agarose  (Fig.  3B).  The  immunoprecipitates  were  then 
immunoblotted with anti-p53 antibody (FL393) (Fig. 3C). 
All exogenous p53 wildtype and mutants were detected 
(Fig. 3B). Though it was not clear if the transactivation 
domain is required for the interaction, these data showed 
that either the N-terminal domain or C-terminal region of 
p53 was sufficient for p53 to maintain an interaction with 
Tid1.
tid1 directly interacts with p53
To determine if these proteins directly interacted or 
whether another protein is involved in the complex, we 
used the in vitro Far Western approach. As the consecutive 
deletion of the C-terminal, Cys-rich and G/F-rich domains 
from the C-terminal end of Tid1 did not appear to interfere 
with the interaction between Tid1 and endogenous p53 
(Fig. 3A), we focused on the domains deleted from the 
N-terminal.  His-tagged Tid1  mutant  proteins  (Fig.  4A) Oncotarget 2010; 1:  396 - 404 www.impactjournals.com/oncotarget 399
Figure 2: cellular localization of p53 full length and its deletion mutants. MCF-7 cells were transfected with p53 constructs to 
overexpress p53 full length or its domain deletion mutants (A) Schematic diagram of p53-DsRed2 full length or domain deletion mutants (B) 
Immunoblotting analysis for p53 and its mutants. (C) p53-DsRed2 transfected cells labeled with anti-mtHsp70 were visualized by confocal 
microscope. (D) Mander’s Overlap Co-efficient between the various p53 constructs and mtHsp70 as determined as described in Fig. 1 D. (E) 
Cellular fraction were obtained as described in Fig. 1 E. 
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were purified. Unfortunately, we were unable to generate 
purified proteins for full length Tid1 or any Tid1 mutants 
possessing the N-terminal domain, in spite of numerous 
efforts to optimize the protein expression. Despite this, 
we were able to obtain the N-terminal-lacking domain 
deletion mutant Tid199-447, which was shown through 
our co-immunoprecipitation to interact with p53. The 
purified  His-tagged  proteins  were  resolved  on  the 
membrane to use as prey proteins. The membrane was 
washed and incubated with the purified N-terminal GST-
tagged  p53  proteins  as  bait,  followed  by  an  anti-GST 
antibody to detect the presence of bait binding. While 
Tid199-447 bound GST-p53, no binding to GST-p53 to 
the Tid1235-447 and Tid1229-447 mutants was detected 
(Fig.  4B).  Unfortunately,  we  were  unable  to  answer 
whether Tid1168-447 bound p53-GST directly (Fig. 4B) 
as anti-GST antibody generated a non-specific band at 
the band size as the mutant (Fig. 4C bottom panel). These 
data imply that Tid1 can bind p53 directly and in this 
interaction, the Cys-rich and C-terminal domains of Tid1 
are not required. 
suppression of tid1 leads to absence of p53 at 
mitochondria and apoptosis following cellular 
stresses
To finally determine if Tid1 has a functional role 
in p53 localization and apoptosis under various cellular 
stresses, we generated MCF-7 cell lines stably suppressing 
Tid1  (Fig.  5A)  by  shRNA.  Cells  in  which  Tid1  was 
knocked  down  (MCF7-shTid1)  had  significantly  less 
mitochondrial p53 (Fig. 5B) and lower levels of apoptosis 
(Fig.  5C)  compared  to  that  seen  in  the  control  under 
treatment  of  either  desferroxamine  mesylate  (DFX),  a 
hypoxia mimetic, or etoposide (ETO), a genotoxic stress. 
This corresponded to previous results from our laboratory 
using DFX but the effects seen here are at higher doses of 
DFX than we previously used [1]. These results further 
extend our previous findings [1] that depletion of Tid1 
expression inhibits hypoxia or genotoxic stress-induced 
p53 mitochondrial localization and apoptosis. Our data 
suggest that the binding of Tid1 to p53 may affect p53’s 
translocation to mitochondria. 
dIscussIon
Protein interactions with the Tid1 tumor suppressor 
have demonstrated the importance of Tid1 in a variety 
of signaling pathways that control cellular growth, 
proliferation, differentiation, senescence, and apoptosis. 
These interactions, like many others, have the requirement 
of proper cellular localization of the proteins in the cell. 
Mislocalization, or sequestration of a protein in different 
cellular compartments, can alter their functional 
interactions and activities. Transcription factors, for 
instance, are required to localize to the nucleus to bind 
to DNA for the induction of transcriptional activity of 
target genes. p53 is a well known transcription factor 
that regulates the expression of over 150 target genes 
involved in cell cycle progression, cellular senescence, 
and apoptosis [2,3,4,5,6]. The loss or mutation of its NLS 
sequences results in the abrogation of nuclear targeting 
and thus its function as a transcription factor. In addition 
Figure 3: dnaJ domain of tid1 and both n- and c-terminal domain of p53 are important for their interaction. (A) Wildtype 
or the different mutant Tid1-EGFP constructs were introduced into MCF-7 (p53wt) cells by Lipofectamine2000 transfection. Cells were lysed, 
immunoprecipitated with the indicated antibodies and immunoblotted with anti-GFP antibodies. Rabbit IgG was used as the negative control 
(B) Wildtype or the different mutant p53-DsRed2 constructs were introduced into MCF-7 (p53wt) cells. Cells were lysed, immunoprecipitated 
with the indicated antibodies and immunoblotted with anti-p53 antibodies. Mouse IgG was used as the negative control. (C) Immunoblotting 
analysis of p53 and its mutants with anti-p53 antibodies.
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Figure 4: tid1 directly interacts with p53. Schematic diagram of His-tagged Tid1 full length or domain deletion mutants (B) Purified 
His-tagged Tid1 mutant proteins were resolved on nitrocellulose membranes, incubated with GST tagged p53 protein and immunoblotted with 
anti-GST antibodies. (C) The membrane loaded with His tagged Tid1 mutant proteins were immunoblotted with anti-His or –GST antibodies.
Figure 5: suppression of tid1 leads to loss of p53 at mitochondria and resistance to apoptosis following cellular stresses. 
MCF-7 cells stably expressing non-silencing shRNA (shScram) or shRNA directed against Tid1 (shTid1) were incubated in the presence or 
absence of 250 μM DFX or 100 μM for ETO 6 hr. (A) Tid1 expression in MCF-7 cells stably expressing shScram or shTid1. (B) Cells labeled 
with anti-p53 antibodies (green) and anti-mtHsp70 antibodies (red) were visualized by confocal microscopy. (C) Apoptotic cells were detected 
by in situ TUNEL assay.
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to this, it was shown that p53 interacts with mtHsp70 
near its C-terminal end, which results in the cytoplasmic 
sequestration of p53 leading to the inactivation of its 
nuclear transactivation function [25,26]. This clearly 
demonstrates the significance of cellular localization of 
p53 protein function.
Although  cytoplasmic  sequestration  compromises 
the transcriptional function of p53, studies have also 
shown it to have a transcription-independent function in 
apoptosis. This function is dependent on its localization to 
the mitochondria. We believe that an interaction with Tid1 
may play a role in this translocation as we have previously 
shown that Tid1 and p53 interact with one another as well 
as co-localize with each other and with the mitochondria 
under conditions of cellular stress [1].
Here, we wanted to test the effects of the loss of 
various domains of both Tid1 and p53 on their cellular 
localization and their ability to interact with one another. 
We found that in the presence of the N-terminal domain, 
and thus the presence of the mitochondrial targeting and 
cleavage sequences, the deletion of the other domains from 
Tid1 did not appear to alter its primarily mitochondrial 
localization. The loss of this domain, on the other hand, 
resulted in the mislocalization and potential aggregation 
of the Tid1 mutants in the cell. Like with many other 
mitochondrial targeted proteins, we have confirmed the 
significance  of  the  N-terminal  domain  in  the  cellular 
localization of this protein.
As  many  mitochondrial  precursor  proteins  are 
encoded by nuclear genes, they are synthesized in the 
cytosol prior to transport to the mitochondria [27]. 
Cytosolic factors and chaperonic proteins, such as 
members of the heat shock 70 family are likely involved 
in the proper folding and prevention of aggregation 
of these precursor proteins [27]. In the absence of this 
N-terminal pre-sequence, not only is targeting to the 
mitochondria lost, but misfolding of the protein appears 
to occur. Although it is beyond the scope of this study, 
there are continuing efforts to determine the exact role 
of the N-terminal domain in protein mislocalization and 
aggregation and its link to cancer.
With our p53 domain deletion constructs, our 
immunofluorescent and biochemical data was, in large part, 
in agreement with the previous findings from Kaul et al., 
[26]. They utilized N-terminal YFP-tagged p53 proteins to 
determine the localization through an immunofluorescent 
approach. This indicates that the large, approximately 
26kDa fluorescent tag does not appear to interfere with 
protein localization. We found that p53-FL was localized 
to all fractions of the cell, although it was primarily 
visualized  to  be  nuclear  through  immunofluorescence. 
This is in slight disagreement with Kaul et al. [26] as 
they concluded that p53-FL is exclusively nuclear. This 
observed difference may be the result of the use of 
an overexpression system and thus mislocalization of 
exogenous protein can occur, depending on the degree of 
overexpression. 
The  absence  of  the  NLS  resulted  in  exclusively 
cytoplasmic protein, but the presence of the NLS with the 
presence of the cytoplasmic sequestration region (amino 
acid residues 323-337) and the mortalin binding domain 
(amino acid residues 312-352), resulted in at least some 
cytoplasmic localization of the p53 mutants [26]. Of note, 
the loss of the N-terminal domain shifted the primary 
localization of the proteins from the nuclear fraction to the 
cytoplasmic fraction. This indicates a possible role of the 
N-terminal domain in addition to the C-terminal domain in 
cytoplasmic  sequestration.  Our  co-immunoprecipitation 
data  indicates  that  the  N-terminal  domain  is  sufficient 
for the interaction with Tid1 and the loss of this domain 
abrogated the formation of the complex. This suggests that 
Tid1 may be involved with mtHsp70 in the translocation 
and cytoplasmic sequestration of p53.
With our Tid1 mutants, we demonstrated the 
significance  of  the  DnaJ  domain  for  interaction  with 
endogenous p53. This indicates an involvement of the heat 
shock 70 family of molecular chaperones, particularly 
of mortalin/mtHsp70 which has already been shown to 
interact with both Tid1 and p53. As DnaJ/DnaK or Hsp40/
Hsp70 interactions are important for proper protein 
folding, translocation, degradation, and the assembly/
disassembly of complexes [16-18], further studies are 
required to determine the exact role of mtHsp70 in the 
Tid1/p53 interaction and perhaps its role in the protein 
aggregation seen in the absence of the N-terminal domain. 
Together, our data implicates a multi-step interaction 
between Tid1 and p53 which involves multiple domains 
on  both  proteins.  Studies  have  already  demonstrated 
the formation of Hsp70/Hsp40/p53 complexes in cells 
providing further evidence supporting our proposed 
model. Sugito et al. [28], provided the first evidence for 
the existence of an Hsp70/mtp53//Hsp40 ternary complex 
and suggested the existence of an Hsp70 (DnaK)/Hsp40 
(DnaJ) chaperone system that is involved in the repair 
of unfolded proteins or mutant p53. The cytosolic form 
of Hsp70, Hsc70, was also found to interact with both 
wildtype and mutant p53, but only in the presence of 
Hsp40 and ATP [29]. The interaction between Hsp40 and 
p53 was shown to be relatively strong, yet the interaction 
between p53 and Hsp70 was weak and transient, 
suggesting that Hsp40 may be the driving factor for the 
formation of stable ternary protein complexes [29]. 
MAterIAls And Methods
Generation of domain deletion Mutant 
constructs
In addition to the full length form of Tid1, we 
generated a total of six domain deletion constructs with Oncotarget 2010; 1:  396 - 404 403 www.impactjournals.com/oncotarget
consecutive domains deleted from either end of the protein 
(Fig 1A). These constructs were cloned into pEGFP-N. 
Similar to the Tid1 domain deletion constructs, p53wt and 
its mutants were cloned into the pDsRed2-N plasmid (Fig. 
2A). For the study of direct interaction, the Tid1wt and 
its mutants constructs were cloned into the pET-22b(+) 
bacterial expression vector that contains C-terminal 
His-tagged fusion proteins. The p53wt construct was 
cloned into the pGEX-4T3 bacterial expression vector 
that  contains  cleavable  N-terminal  GST-tagged  fusion 
proteins. 
cell culture and transfection
The human breast cancer cell line MCF-7 was 
grown in Dulbelcco’s Modified Eagle Medium (DMEM, 
Invitrogen)  supplemented  with  10%  fetal  bovine 
serum  (FBS,  Invitrogen)  and  antibiotics-antimycotics 
(Invitrogen).  Cells  were  tranfected  with  5-10µg  of 
plasmid  DNA  in  10cm  plate  using  Lipofectamine2000 
(Invitrogen) according to the manufacturer’s instructions 
subcellular Fractionation, Immunoprecipitation, 
Immunoblotting and confocal Microscopy
These methods were performed as described in our 
previous study [1]. Anti-p53 (FL-393), anti-Tid1 (RS-11), 
anti-β-tubulin  (H-235),  anti-GFP  (B2)  or  anti-DsRed2 
(Santa  Cruz  Biotechnology)  and  anti-mtHsp70  (MA3-
028,  Transduction  Labs,  Oxford,  UK)  antibodies  were 
used for immunoprecipitation or immunoblotting. For 
confocal microscopy, stained cells were examined using 
a Zeiss LSM 510 Laser Scanning Confocal Microscope.
Protein Amplification and Purification
Both the pET-22b-Tid1 and pGEX-4T3-p53 bacterial 
constructs were transformed into BL21 cells chemically 
competent cells for the expression of our genes of interest. 
These were then purified using the Ni-NTA agarose system 
(for  His-tagged  constructs)  or  Glutathione-Sepharose 
beads  (for  GST  tagged  constructs),  respectively.  The 
purity  of  all  our  protein  was  >90%  as  determined  by 
SDS-PAGE Coomassie Brilliant Blue staining (data not 
shown). 
Far westerns
1 µg of purified His-tagged Tid1 mutants were run on 
SDS-PAGE and transferred to nitrocellulose membrane. 
The membranes were then denatured and re-natured using 
AC buffer containing 6M Guanidine-HCl (Sigma) for 30 
minutes at room temperature, 3M Guanidine-HCl for 30 
minutes at room temperature, 1M Guanidine-HCl for 30 
minutes at room temperature, 0.1M Guanidine-HCl for 30 
minutes at 4°C, and no Guanidine-HCl overnight at 4°C. 
Membranes were washed 3 times with PBST, blocked for 
1 hour in 5% skim milk in PBST, and incubated with 5µg 
of bait protein in binding buffer (100mM NaCl, 20mM Tris 
[pH 7.6], 0.5mM EDTA, 10% glycerol, 0.1% Tween-20, 
2%  skim  milk  powder  and  1mM  Dithiothreitol  [DTT, 
Sigma]) overnight at 4°C. Bound bait protein was detected 
by a primary antibody in a method similar to standard 
Immunoblotting described. Membranes were stripped and 
reprobed using standard Immunoblotting to determine the 
position of the prey proteins on the membrane. Anti-His 
(H-15) and anti-GST (1-109) (Santacruz Biotechnology) 
were used for detection of the tagged constructs.
tid1 Knock down and stable cell lines
MCF7 cells were infected with retrovirus 
amplified  from  pRetroSuper  constructs  containing 
short  hairpin  RNA  (shRNA)  directed  against  Tid1 
(shTid1,  5’-CAGCTACGGCTACGGAGAC-3’) 
or  non-silencing  shRNA  (shSCRAM, 
5’-AATTCTCCGAACGTGTCACGT-3’)  and  selected 
for two weeks in puromycin (1 µg/mL). 
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